{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:31Z","timestamp":1707524311068},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,5]]},"DOI":"10.7759\/cureus.17731","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T17:59:49Z","timestamp":1630951189000},"source":"Crossref","is-referenced-by-count":1,"title":["The Long-Term Characteristics of Immunity Conferred by COVID-19 Using Antibody Tests"],"prefix":"10.7759","author":[{"given":"Faryal","family":"Shoaib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashaam","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran N","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazanfar","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland GA","year":"2020","unstructured":"Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020, 396:1595-606. 10.1016\/S0140-6736(20)32137-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22034-1","article-title":"SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19","volume":"12","author":"Wu J","year":"2021","unstructured":"Wu J, Liang B, Chen C, et al.. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. Nat Commun. 2021, 12:1813. 10.1038\/s41467-021-22034-1","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12977","article-title":"COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts","volume":"302","author":"John AE","year":"2021","unstructured":"John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021, 302:228-40. 10.1111\/imr.12977","journal-title":"Immunol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/oca.2748","article-title":"Analysis of COVID-19 and comorbidity co-infection model with optimal control","author":"Omame A","year":"2021","unstructured":"Omame A, Sene N, Nometa I, Nwakanma CI, Nwafor EU, Iheonu NO, Okuonghae D. Analysis of COVID-19 and comorbidity co-infection model with optimal control. Optim Control Appl Methods. 2021, 10.1002\/oca.2748","journal-title":"Optim Control Appl Methods"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.04.055","article-title":"Understanding antibody testing for COVID-19","volume":"35","author":"Jacofsky D","year":"2020","unstructured":"Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty. 2020, 35:S74-81. 10.1016\/j.arth.2020.04.055","journal-title":"J Arthroplasty"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106519","article-title":"SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment","volume":"84","author":"di Mauro G","year":"2020","unstructured":"di Mauro G, Scavone C, Rafaniello C, Rossi F, Capuano A. SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment. Int Immunopharmacol. 2020, 84:106519. 10.1016\/j.intimp.2020.106519","journal-title":"Int Immunopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang S","year":"2020","unstructured":"Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020, 41:355-9. 10.1016\/j.it.2020.03.007","journal-title":"Trends Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou X","year":"2020","unstructured":"Ou X, Liu Y, Lei X, et al.. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020, 11:1620. 10.1038\/s41467-020-15562-9","journal-title":"Nat Commun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai W","year":"2020","unstructured":"Tai W, He L, Zhang X, et al.. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020, 17:613-20. 10.1038\/s41423-020-0400-4","journal-title":"Cell Mol Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba NM","year":"2020","unstructured":"Okba NM, M\u00fcller MA, Li W, et al.. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020, 26:1478-88. 10.3201\/eid2607.200841","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV- 2: an observational cohort study","volume":"20","author":"To KK","year":"2020","unstructured":"To KK, Tsang OT, Leung WS, et al.. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV- 2: an observational cohort study. Lancet Infect Dis. 2020, 20:565-74. 10.1016\/S1473-3099(20)30196-1","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"71","author":"Guo L","year":"2020","unstructured":"Guo L, Ren L, Yang S, et al.. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020, 71:778-85. 10.1093\/cid\/ciaa310","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao J","year":"2020","unstructured":"Zhao J, Yuan Q, Wang H, et al.. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020, 71:2027-34. 10.1093\/cid\/ciaa344","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel R","year":"2020","unstructured":"W\u00f6lfel R, Corman VM, Guggemos W, et al.. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020, 581:465-9. 10.1038\/s41586-020-2196-x","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1086\/422040","article-title":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid","volume":"190","author":"Leung DT","year":"2004","unstructured":"Leung DT, Tam FC, Ma CH, et al.. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis. 2004, 190:379-86. 10.1086\/422040","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4236\/odem.2021.91003","article-title":"Prevalence and pattern of COVID-19 among healthcare workers in Rivers State Nigeria","volume":"9","author":"Alasia D","year":"2021","unstructured":"Alasia D, Maduka O. Prevalence and pattern of COVID-19 among healthcare workers in Rivers State Nigeria. Occup Dis Environ Med. 2021, 9:20-32. 10.4236\/odem.2021.91003","journal-title":"Occup Dis Environ Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin JM","year":"2020","unstructured":"Jin JM, Bai P, He W, et al.. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020, 8:152. 10.3389\/fpubh.2020.00152","journal-title":"Front Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242768","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait","volume":"15","author":"Alshukry A","year":"2020","unstructured":"Alshukry A, Ali H, Ali Y, et al.. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. PLoS One. 2020, 15:e0242768. 10.1371\/journal.pone.0242768","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan JM","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, et al.. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021, 371:10.1126\/science.abf4063","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.47144\/phj.v53i1.1911","article-title":"Recurrent COVID-19 infection in recovered patients (a critical review)","volume":"53","author":"Muhammad A","year":"2020","unstructured":"Muhammad A. Recurrent COVID-19 infection in recovered patients (a critical review). Pak Heart J. 2020, 53:24-7. 10.47144\/phj.v53i1.1911","journal-title":"Pak Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study","volume":"397","author":"Hansen CH","year":"2021","unstructured":"Hansen CH, Michlmayr D, Gubbels SM, M\u00f8lbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021, 397:1204-12. 10.1016\/S0140-6736(21)00575-4","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.01.020","article-title":"Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers","volume":"82","author":"dos Santos LA","year":"2021","unstructured":"dos Santos LA, de G\u00f3is Filho PG, Silva AMF, et al.. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infect. 2021, 82:399-406. 10.1016\/j.jinf.2021.01.020","journal-title":"J Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66740-the-long-term-characteristics-of-immunity-conferred-by-covid-19-using-antibody-tests","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:17Z","timestamp":1707506957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66740-the-long-term-characteristics-of-immunity-conferred-by-covid-19-using-antibody-tests"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,5]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.17731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,5]]}}}